Bliss GVS Pharma
BLISSGVS.NS
£1.34
Share price
0.26%
Change (1 day)
18.39%
Change (1 year)
Categories
Operating Margin for Bliss GVS Pharma (BLISSGVS.NS)
Operating Margin as of July 2025 (TTM): 16.51%
According to Bliss GVS Pharma's latest financial reports and stock price the company's current Operating Margin is 16.51%. At the end of 2025 the company had an Operating Margin of 15.52%.
Operating Margin history for Bliss GVS Pharma from 2013 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 15.52% | 2.26% |
| 2024 | 15.17% | 6.92% |
| 2023 | 14.19% | 93.34% |
| 2022 | 7.34% | -59.91% |
| 2021 | 18.31% | -3.18% |
| 2020 | 18.91% | -7.84% |
| 2019 | 20.52% | 16.67% |
| 2018 | 17.59% | -24.52% |
| 2017 | 23.30% | -14% |
| 2016 | 27.10% | 14.9% |
| 2015 | 23.58% | 15.2% |
| 2014 | 20.47% | -25.83% |
| 2013 | 27.60% | -7.18% |
| 2012 | 29.74% | 22.83% |
| 2011 | 24.21% | -10.64% |
| 2010 | 27.09% | -10.51% |
| 2009 | 30.28% | -12.01% |
| 2008 | 34.41% | 265.8% |
| 2007 | 9.41% |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.